Latest Articles
Whitehawk Therapeutics Presents Real-World Analysis Confirming MUC16 as Highly Expressed, Clinically Relevant Target for Gynecologic Cancers - National Today
Whitehawk Therapeutics Presents Real-World Analysis Confirming MUC16 as Highly Expressed, Clinically Relevant Target for Gynecologic Cancers National Today
Published: April 10, 2026, 4:35 p.m.
In ovarian cancer, one drug target towers up to 100-fold above rivals - Stock Titan
In ovarian cancer, one drug target towers up to 100-fold above rivals Stock Titan
Published: April 10, 2026, 11 a.m.
"Targeted supports" launched for former patients of Simon Gordon - HospitalHealth.com.au
"Targeted supports" launched for former patients of Simon Gordon HospitalHealth.com.au
Published: April 7, 2026, 12:35 a.m.
Irvine Biotech Firm Targets Endometriosis with New Therapy - Orange County Business Journal
Irvine Biotech Firm Targets Endometriosis with New Therapy Orange County Business Journal
Published: April 6, 2026, 3:58 p.m.
Improving the chances of parenthood with endometrium-targeted mRNA - BioXconomy
Improving the chances of parenthood with endometrium-targeted mRNA BioXconomy
Published: April 3, 2026, 1:40 p.m.
Improving the chances of parenthood with endometrium-targeted mRNA - bioxconomy.com
Improving the chances of parenthood with endometrium-targeted mRNA bioxconomy.com
Published: April 3, 2026, 1:40 p.m.
Insilico Medicine and ASKA Pharmaceutical Partner to Discover Novel Drug Targets for Endometriosis, Fibroids and Adenomyosis - Femtech Insider
Insilico Medicine and ASKA Pharmaceutical Partner to Discover Novel Drug Targets for Endometriosis, Fibroids and Adenomyosis Femtech Insider
Published: March 25, 2026, 12:34 p.m.
Insilico Medicine and ASKA Pharma expand partnership to discover novel targets for women’s health - BioSpectrum Asia
Insilico Medicine and ASKA Pharma expand partnership to discover novel targets for women’s health BioSpectrum Asia
Published: March 25, 2026, 6:37 a.m.
HerAnova Commercializes Blood Test for Endometriosis Detection, Targeting Years-Long Diagnostic Delays - R&D World
HerAnova Commercializes Blood Test for Endometriosis Detection, Targeting Years-Long Diagnostic Delays R&D World
Published: March 16, 2026, 9:31 p.m.
Universal, Off-the-Shelf Immunotherapy Targets and Eliminates Endometrial Cancer - Bioengineer.org
Universal, Off-the-Shelf Immunotherapy Targets and Eliminates Endometrial Cancer Bioengineer.org
Published: March 16, 2026, 9:20 p.m.
Link copied to clipboard!